consecutive patients undergoing catheter ablation for post-MI VT were enrolled. Inclusion criteria were history of MI and drug-resistant sustained VT. Exclusion
C atheter ablation is an effective technique for the management of post-myocardial infarction ventricular tachycardia (post-MI VT). [1] [2] [3] The role of substrate-based VT ablation techniques is expanding. [4] [5] [6] [7] In this context, elimination of local abnormal ventricular activities (LAVA) has emerged as an important end point for VT ablation. 7 During the past decade, the emergence of innovations, such as three-dimensional electroanatomic mapping (3D-EAM), 8 multipolar catheters for high-density mapping, 7 and real-time integration of structural VT substrate from imaging, have enhanced our ability to identify ablation targets. 9 However, the impact of these technological innovations on ablation outcome has not been systematically studied. 1, [10] [11] [12] [13] [14] The purpose of this study is to identify the impact of these innovations on ablation outcome for post-MI VT. New Technologies and Approaches for VT Ablation criteria were presence of intracardiac thrombus, New York Heart Association class IV heart failure, and cardiac surgery within the past 2 months (unless VT was incessant). VT storm was defined as ≥3 VT episodes in 24 hours.
All patients underwent catheter ablation with the same end point, that is, complete LAVA elimination during sinus rhythm (SR) 7 and noninducibility of any VT, but with various methods according to the evolution of EP technology during the course of the study. The use of 3D-EAM, multipolar catheters, and real-time image integration was solely based on the availability of the technology and was independent of patient characteristics (except for contraindications to contrast-enhanced multidetector computed tomography [MDCT] and magnetic resonance imaging [MRI] ). This study was approved by the Institutional Review Board, and all patients gave informed consent.
Electrophysiological Mapping Study
Procedures were performed under conscious sedation. A 5F, steerable, quadripolar/decapolar catheter (Xtrem; Sorin, France, or Dynamic; BostonScientific, Inc, Cambridge, MA) was placed in the right ventricular apex or coronary sinus. The left ventricle was accessed by a transseptal (BRK Needle, Agilis Sheath; St Jude Medical, St Paul, MN) or retrograde aortic approach. Epicardial mapping (Tuohy Needle, Agilis Sheath; St Jude Medical) was performed 15 in cases with suspected epicardial VT origin (from 12-lead ECG and/or absence of endocardial LAVA and/or failure of endocardial ablation). Contraindications to epicardial access included previous cardiac surgery and pericardial adhesions. After left ventricle access, a 50 U/kg heparin bolus was administered (activated clotting time maintained at >250 seconds). Twelve-lead ECG and intracardiac electrograms were recorded continuously (LabSystem Pro; Bard Electrophysiology, MA, or Siemens Axiom Sensis XP; Siemens, Munich, Germany).
Mapping was performed using either a 3.5-mm open-irrigated catheter (NaviStar ThermoCool; Biosense Webster, Diamond Bar, CA) and/or a multipolar high-density mapping catheter (PentaRay; 2-6-2 mm interelectrode spacing, 1 mm electrodes; Biosense Webster). Peak-to-peak amplitudes of 0.5 to 1.5 mV and <0.5 mV were used to define the low-voltage zone and the dense scar zone,
WHAT IS KNOWN
• Elimination of LAVA has emerged as an important end point for VT ablation.
• Many technical innovations for VT ablation
were introduced over the past years, including 3D-mapping system, image integration, and multipolar mapping catheter. However, the impact of these novel techniques on the clinical outcome of post-MI VT ablation has not been thoroughly investigated.
WHAT THE STUDY ADDS
• The ability to achieve complete LAVA elimination, the use of image integration, and highdensity mapping with multipolar catheters are independent predictors of VT-free survival after catheter ablation for post-MI VT.
• Aiming for complete LAVA elimination using real-time image integration and multipolar catheter is a feasible and useful approach in patients with post-MI VT. Flow chart for ventricular tachycardia (VT) ablation in post-myocardial infarction (post-MI) patients. *In case with no local abnormal ventricular activity (LAVA) during sinus rhythm (SR), ablation was guided by pace mapping. †LAVA-guided ablation was limited in case LAVA located near coronary arteries and phrenic nerve on the epicardium or persisted after extensive ablation. ‡In case of intolerable VTs with cardioversion >2 times during the procedure, VT inducibility was not tested.
respectively. When a 3D-EAM system was used (CARTO3; Biosense Webster, or NavX; St Jude Medical), mapping was performed during SR to create a voltage map and annotate LAVA. For hemodynamically tolerated VT, activation mapping was performed during VT.
For image integration, structural substrate was derived from MDCT or MRI. Images were processed using dedicated software (MUSIC; Liryc-Université de Bordeaux/Inria-Sophia Antipolis, France) to render patient-specific meshes of the cardiac chambers, epicardium, coronary sinus, and coronary arteries and left phrenic nerve in case of epicardial approach. 16 The structural substrate was segmented on imaging as areas of late gadolinium enhancement on MRI and/or areas of wall thinning <5 mm on MDCT. 9 The imaging model was registered to the mapping geometry using landmark-based registration and field scaling when using NavX system or landmarkbased registration and automatic surface registration when using CARTO system.
VT Inducibility and Ablation
A flow chart illustrating procedural management is provided in Figure 1 . VT inducibility was assessed at the beginning of the procedure (600 and 400 ms drive trains, ≤3 extrastimuli decremented to 200 ms from the right ventricular apex). If hemodynamically stable VT was induced, conventional activation and entrainment was performed. 17 For noninducible or poorly tolerated VT, mapping was undertaken to identify LAVA during SR. LAVA was defined as sharp high-frequency ventricular potentials, distinct from the far-field ventricular electrogram occurring anytime during or after the far-field ventricular electrogram in SR. 7 Radiofrequency current was delivered with an irrigated catheter (25-50 W endocardial and 25-35 W 
Follow-Up
Patients were followed up with sequential implantable cardioverter-defibrillator (ICD) interrogations (or Holter monitoring in patients without ICD) at 1, 3, 6, and 12 months for the first year and subsequently every 6 months. The primary end point was VT recurrence. Qualifying arrhythmias included any VT detected by ICDs, 12-lead ECGs, Holter monitors, or rhythm strips, regardless of morphology or rate. Death during follow-up was categorized as either cardiovascular or noncardiovascular. Among cardiovascular deaths, sudden deaths attributed to ventricular arrhythmia were recorded.
Statistical Analysis
Shapiro-Wilk and D'Agostino tests were used to assess whether quantitative data conformed to the normal distribution. Log transformation was applied in case of non-normal distribution. Continuous variables are expressed as mean±SD (normally distribution) and median (interquartile range; non-normal distribution 
Mapping and Ablation Procedure
Transseptal, retrograde aortic, and epicardial approaches were performed in 124 (87%), 48 (34%), and 52 cases (37%), respectively. Criteria for epicardial access were met in 64 cases (45%), in whom pericardial access was not possible in 12 cases (3 cases because of pericardial adhesion; 7 cases After Bonferroni correction to account for multiple testing, a P value <0.002 is considered to indicate statistical significance. 3D-EAM indicates 3-dimensional electroanatomical mapping; CI, confidence interval; DCC, direct current cardioversion; LAVA, local abnormal ventricular activity; RF, radiofrequency; VF, ventricular fibrillation; and VT, ventricular tachycardia.
*Not assessable because inducibility was not tested again when the arrhythmia induced at baseline was poorly tolerated. New Technologies and Approaches for VT Ablation After Bonferroni correction to account for multiple testing, a P value <0.002 is considered to indicate statistical significance in univariable analyses. The criterion for entry in the multivariable model was P<0.05. 3D-EAM indicates 3-dimensional electroanatomical mapping; CI, confidence interval; DCC, direct current cardioversion; LAVA, local abnormal ventricular activity; RF, radiofrequency; VF, ventricular fibrillation; and VT, ventricular tachycardia.
*Mapping characteristics were not considered as candidates for multivariable analysis because these were only present in patients with 3D-EAM. New Technologies and Approaches for VT Ablation because of previous cardiac surgery; 1 case because of a risk of bleeding by dual-antiplatelet therapy; and 1 case because of pericardial bleeding). A multipolar mapping catheter was used in 73 cases (51%). 3D-EAM was performed in 99 cases (70%) and associated with real-time integration of anatomy and scar from imaging in 54 cases (38%). Real-time image integration consisted of MDCT data in 50 cases (93%), MRI data in 21 cases (39%), and fused MDCT and MRI data in 17 cases (31%). A representative example of real-time integration and high-density mapping with a multipolar catheter is illustrated in Figure 2 . Procedural findings are summarized in Table 1 . VT was inducible at baseline in 106 cases (75%). LAVAs were found on the endocardium in 125 cases (88%) and on the epicardium in 39 cases (75% of patients with epicardial access). A total of 216 VTs were induced, 55(25%) of which were mapped and terminated by radiofrequency application, and 161(75%) of which were unmappable because of hemodynamic intolerance, conversion to another VT during mapping, or spontaneous termination. After a total radiofrequency time of 32 minutes (interquartile range, 20-50), complete LAVA elimination was achieved in 79 cases (60% of patients with LAVA). At the end of the procedure, VT inducibility was not tested in 30 out of 142 patients (21%) because of the induction of poorly tolerated VTs requiring cardioversion >2 times during the procedure. Of the remaining 112 cases who underwent programmed stimulation, the end point of VT noninducibility was achieved in 93 out of 112 patients (83%). Eight patients had pericardial bleeding (5 related to epicardial approach). One patient required surgery, whereas the others resolved spontaneously. Permanent atrioventricular block occurred in 1 patient. There were no strokes, phrenic palsies, coronary injuries, or procedure-related deaths.
Follow-Up
Follow-up characteristics are summarized in Table 1 . One hundred out of 125 patients (80%) had an ICD implanted before VT ablation. A further 3 patients had an ICD implanted after VT ablation. After a median follow-up of 850 days (interquartile range, 439-1707), VT recurred in 53 out of 146 patients (36%), in which VTs were detected by the ICD (requiring antitachycardia pacing or shock) in 48 patients and recorded by the ambulance monitor or 12-lead ECG in the remaining 5 patients. Death from all causes occurred in 20 out of patients 125(16%), death from cardiac causes in 14 out 125 patients (11%), and sudden death attributed to electrical storm in 5 out of 125 patients (4%), despite ICD therapy.
Factors Associated With Procedural End Points
Results from univariable analysis for the prediction of complete LAVA elimination and noninducibility of VT are shown in Table 2 . The ability to achieve complete LAVA elimination or VT noninducibility was not related to any baseline characteristics. Among procedural characteristics, low-voltage zone and dense scar zone tended to be associated with failure to achieve LAVA elimination, although the association did not reach significance after Bonferroni correction to account for multiple testing (P=0.006 and P=0.005, respectively). Baseline inducibility was associated with a lower rate of noninducibility at the end of the procedure (P=0.002). Total radiofrequency and procedure time were also associated with lower rates of noninducibility at the end of the procedure (P=0.0003 and P=0.002, respectively).
Factors Associated With Clinical Outcome
Results from univariable and multivariable analyses for the prediction of VT recurrence are summarized in Table 3 . On multivariable analysis, 3 characteristics were associated with the outcome: (1) the ability to achieve complete LAVA elimination (R 2 =0.29; P<0.0001; risk ratio 0.52 [0.38-0.70]), (2) the use of real-time image integration (R 2 =0.21; P=0.0006; risk ratio 0.49 [0.33-0.74]), and (3) the use of multipolar catheters (R 2 =0.08; P=0.05; risk ratio 0.75 [0.56-1.00]). Kaplan-Meier graphs illustrating the impact of these characteristics on VT-free survival are shown in Figures 3-5 .
Procedural data in patients with versus without multipolar catheters and image integration are compared in Table 4 . Patients with multipolar catheters showed higher rates of transseptal and epicardial approaches (P=0.01 and P<0.0001, respectively), higher numbers of endocardial mapping points (P<0.0001), and higher rate of endocardial LAVA (96% versus 80%; P=0.002). Patients with real-time image integration showed higher numbers of endocardial LAVA sites (43 versus 24 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] ; P=0.03).
Follow-up at 1 year was available for 23 patients in whom both multielectrode mapping and image integration had been used. In this population, LAVA elimination had been achieved in 18 out of 23 patients (78%), and 20 out of 23 patients (87%) were free from recurrence at 1-year follow-up.
Discussion
This study is to our knowledge the first to analyze the incremental effect of recent technological innovations on the efficacy of post-MI VT ablation. Using constant procedural end points in a cohort of post-MI VT patients, we demonstrate that complete LAVA elimination, scar integration from imaging, and high-density mapping with multipolar catheters are independent predictors of postablation, VTfree survival.
Impact of LAVA Elimination
Complete LAVA elimination was associated with a 2-fold reduction in risk of VT recurrence in our cohort. VT noninducibility on the contrary did not influence outcome. These findings provide further evidence that LAVA elimination of VT substrate is an efficient procedural end point. 7, 18 The low predictive value of VT noninducibility is also consistent with many previous studies. 19, 20 
Impact of Real-Time Image Integration
Real-time image integration was shown to be feasible with processing times compatible with routine clinical practice. Previous studies have reported good accuracy in identifying VT substrate, using MDCT, MRI, 9 or positron emission tomography. 21 Voltage mapping may fail to accurately delineate the extent of diseased myocardium because of limitations such as catheter contact issues, reduced sensitivity to far-field signal in nontransmural or midwall scar, 22 and epicardial fat interposition. 23 Additionally, the density and comprehensiveness of voltage mapping is highly dependent on operator decisions and time constraints, whereas imaging methods provide whole-heart assessment of the structural substrate with submillimetric spatial resolution in a few heartbeats. Therefore, integrating the structural substrate as defined from preprocedural imaging might improve the accuracy of mapping in identifying ablation targets.
In this study, the integration of anatomy and scar from imaging was associated with a 2-fold reduction in VT recurrence. The superior outcome in patients with image integration might be explained by the ability of imaging to comprehensively describe the structural substrate of VT, thereby enabling a more focused mapping on critical areas, at the same time ensuring that no abnormal myocardium is left unexplored. Interestingly, we identified a higher number of LAVA sites in patients with real-time image integration despite a similar number of mapping points. This observation confirms that mapping is more efficiently focused toward critical areas when guided by imaging data. Of note, however, the identification of more LAVA did not translate into higher rates of complete LAVA elimination. Therefore, the impact of image integration on outcome seems to be mediated by a more comprehensive treatment of VT substrate; however, the issue of unreachable targets remains (midwall circuits and coronary interposition). 24 In this study, VT-free survival rates in the population without image integration were comparable to those reported in the VTACH study (Ventricular Tachycardia Ablation in Coronary Heart Disease), 13 whereas the outcome in patients treated with image integration was more favorable. However, this latter outcome was similar to a previous study by Deneke et al 14 that did not use image integration (77% VT-free survival rate during a median follow-up of 16 months). This is likely because of differences in patient characteristics between studies because VTs with suspected epicardial origin, noninducible clinical VTs, and ongoing VTs during the procedure were excluded in the study by Deneke et al. 14 Moreover, in this study, poorly tolerated VTs requiring cardioversion >2 times during the procedure were observed in 21% of cases, which suggests a severe condition in the included population. 
Impact of Multipolar Catheters
High-density mapping with multipolar catheters has been reported to enhance accurate depiction of slow conducting areas during SR and improves understanding of VT mechanisms. 7, 25, 26 However, the impact of this technology on ablation outcome has not been defined. In this study, the use of multipolar catheters was associated with a lower VT recurrence rate in patients with post-MI VT. Consistent with a recent report from our group 27 , mapping with multipolar catheters was associated with a higher mapping density that translated into a higher rate of endocardial LAVA identification. The rate of complete LAVA elimination tended to be higher when using multipolar catheters. This might be explained by a more mechanistic understanding of slow conduction areas during SR and therefore by a more efficient targeting of the entry site to interconnected channels. 28 Overall, the impact of multipolar catheters on patient outcome seems to be mediated by a more comprehensive treatment of VT substrate.
Study Limitations
The objective of this study was to evaluate the impact of technological advances on efficacy of VT ablation. Therefore, a 3D-EAM indicates 3-dimensional electroanatomical mapping; DCC, direct current cardioversion; LAVA, local abnormal ventricular activity; RF, radiofrequency; RII, real-time image integration; and VT, ventricular tachycardia.
*Applies to patients with 3D-EAM. †Among patients with epicardial access. ‡Among patients with inducibility testing. §Among patients with LAVA. New Technologies and Approaches for VT Ablation retrospective nature was mandatory. We acknowledge that the use of different techniques during the course of the study likely led to a systematic underestimation of the impact of baseline characteristics. The impact of image integration and multipolar catheters on patient outcome after post-MI VT ablation should be confirmed in a randomized-controlled fashion. The second limitation of this study is related to its sample size, which particularly prevented us from analyzing predictors of mortality. Indeed, only 4 patients experienced sudden deaths attributed to arrhythmia recurrence in the studied population. Third, one of the inherent limitations of the nonrandomized study design is a potential confounding effect of accumulating experience for one technique influencing outcome of subsequently introduced techniques. Although this effect is negated to a degree by the fact that procedures were performed by specialists in VT ablation with >10 years of experience, it remains a potential confounding factor. Another potential bias would be an evolution in the indication to perform VT ablation during the course of the study. However, this indication remained unchanged, and particularly, the baseline characteristics (age, sex, previous percutaneous coronary intervention, previous coronary artery bypass graft, ICD, left ventricular ejection fraction, VT storm, and number of past procedures and drugs) did not differ between patients with and without image integration and between patients with and without multipolar catheters.
Conclusions
We demonstrate that the ability to achieve complete LAVA elimination, the integration of scar data from preprocedural imaging, and the use of multipolar catheters to perform high-density mapping enhances VT-free survival after post-MI VT ablation. Our results further confirm that complete LAVA elimination is a procedural end point of high predictive value.
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